Skip to main content
Earnings Labs
Stoke Therapeutics, Inc. logo

Stoke Therapeutics, Inc. (STOK)

NASDAQ·Healthcare·Biotechnology

$26.51

-0.13%

Mkt Cap $1.70B

Analyst Ratings

Buy

4

Hold

0

Sell

0

Price Target (19 analysts)

$51.00

Range $44.00 – $58.00

Implied Upside

+92.4%

Consensus $51.00 vs current $26.51